TW200621785A - Analgesic - Google Patents

Analgesic

Info

Publication number
TW200621785A
TW200621785A TW094138512A TW94138512A TW200621785A TW 200621785 A TW200621785 A TW 200621785A TW 094138512 A TW094138512 A TW 094138512A TW 94138512 A TW94138512 A TW 94138512A TW 200621785 A TW200621785 A TW 200621785A
Authority
TW
Taiwan
Prior art keywords
provides
analgesic
present
various
subsitituent
Prior art date
Application number
TW094138512A
Other languages
English (en)
Chinese (zh)
Other versions
TWI356826B (cg-RX-API-DMAC7.html
Inventor
Naoki Izumimoto
Kuniaki Kawamura
Toshikazu Komagata
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of TW200621785A publication Critical patent/TW200621785A/zh
Application granted granted Critical
Publication of TWI356826B publication Critical patent/TWI356826B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08Oxygen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW094138512A 2004-11-04 2005-11-03 Analgesic TW200621785A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004320583 2004-11-04

Publications (2)

Publication Number Publication Date
TW200621785A true TW200621785A (en) 2006-07-01
TWI356826B TWI356826B (cg-RX-API-DMAC7.html) 2012-01-21

Family

ID=36319248

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094138512A TW200621785A (en) 2004-11-04 2005-11-03 Analgesic

Country Status (12)

Country Link
US (1) US8470845B2 (cg-RX-API-DMAC7.html)
EP (1) EP1820505A4 (cg-RX-API-DMAC7.html)
JP (1) JP4706636B2 (cg-RX-API-DMAC7.html)
KR (1) KR101285645B1 (cg-RX-API-DMAC7.html)
CN (1) CN101090722B (cg-RX-API-DMAC7.html)
AR (1) AR053098A1 (cg-RX-API-DMAC7.html)
CA (1) CA2586181C (cg-RX-API-DMAC7.html)
MX (1) MX2007005336A (cg-RX-API-DMAC7.html)
NO (1) NO20072832L (cg-RX-API-DMAC7.html)
PE (1) PE20060723A1 (cg-RX-API-DMAC7.html)
TW (1) TW200621785A (cg-RX-API-DMAC7.html)
WO (1) WO2006049248A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5119925B2 (ja) 2005-11-09 2013-01-16 東レ株式会社 機能性腸障害の治療または予防剤
CA2634055C (en) * 2005-12-21 2011-07-05 Toray Industries, Inc. Antitussive agent
FR2902341B1 (fr) 2006-06-16 2011-02-25 Scras Utilisation therapeutique simultanee, separee ou etalee dans le temps d'au moins une neurotoxine botulique, et d'au moins un derive opiace
FR2910327B1 (fr) 2006-12-22 2013-04-26 Scras Utilisation d'au moins une neurotoxine botulique pour traiter la douleur induite par les traitements therapeutiques du virus du sida.
KR101546398B1 (ko) * 2007-05-21 2015-08-26 도레이 카부시키가이샤 결정성 미분화 입자
KR101510799B1 (ko) * 2007-05-21 2015-04-10 도레이 카부시키가이샤 의약 정제의 제조법
CN101848713B (zh) * 2007-05-21 2012-04-11 东丽株式会社 含有特定的有机酸的口服制剂以及口服制剂的溶出性和化学稳定性的改善方法
FR2930447B1 (fr) 2008-04-25 2010-07-30 Sod Conseils Rech Applic Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur dans le cas de la neuropathie diabetique
HUE069820T2 (hu) 2018-03-08 2025-04-28 Victoria Link Ltd Nalfurafin alkalmazása demielinizációs betegségek kezelésére

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4118823B1 (cg-RX-API-DMAC7.html) * 1964-02-03 1966-10-31
US3318886A (en) * 1965-07-21 1967-05-09 American Cyanamid Co Substituted 7-hydroxymethyl-7, 8-dihydro-6-amino-6, 14-endoethenocodides and morphide
NL8102558A (nl) * 1981-05-25 1982-12-16 Alcoa Nederland Bv Lichtmast met versterking van de opening in het onderste gedeelte.
JP2525552B2 (ja) * 1992-01-23 1996-08-21 東レ株式会社 モルヒナン誘導体および医薬用途
DE69424853T2 (de) 1993-07-23 2000-10-05 Toray Industries, Inc. Morphinan-derivate und ihre medizinische verwendung
ATE259232T1 (de) 1995-03-03 2004-02-15 Endo Pharmaceuticals Inc Verwendung von dextromethorphan oder dextrorphan zur behandlung der harninkontinenz
CN1374963A (zh) 1999-07-19 2002-10-16 东丽株式会社 尿频或尿失禁的治疗或预防剂
DE19939044A1 (de) * 1999-08-18 2001-03-15 Gruenenthal Gmbh Verwendung von Morphinanderivaten als Arzneimittel
DE60133584T2 (de) * 2000-10-31 2009-06-04 Rensselaer Polytechnic Institute 4-arylpiperidine als opioidrezeptorbindende agenzien
EP1555266B1 (en) 2002-10-09 2014-05-21 Toray Industries, Inc. Remedies or preventives for urinary incontinence and morphinan derivatives having nitrogen-containing heterocyclic group
JP4118824B2 (ja) 2004-02-24 2008-07-16 株式会社日立製作所 優先パケットの遅延を最小化するシェーピング装置
JP4118826B2 (ja) 2004-03-01 2008-07-16 リオン株式会社 補聴器用ケースなどの製造方法及びその装置
US7718664B2 (en) 2004-03-30 2010-05-18 Toray Industries, Inc. Anti-itching agent

Also Published As

Publication number Publication date
US20070299100A1 (en) 2007-12-27
TWI356826B (cg-RX-API-DMAC7.html) 2012-01-21
JP4706636B2 (ja) 2011-06-22
WO2006049248A1 (ja) 2006-05-11
US8470845B2 (en) 2013-06-25
CA2586181C (en) 2012-11-27
MX2007005336A (es) 2007-06-25
EP1820505A1 (en) 2007-08-22
EP1820505A4 (en) 2010-01-20
JPWO2006049248A1 (ja) 2008-08-07
CN101090722A (zh) 2007-12-19
KR20070085436A (ko) 2007-08-27
HK1115808A1 (en) 2008-12-12
CA2586181A1 (en) 2006-05-11
PE20060723A1 (es) 2006-08-29
CN101090722B (zh) 2011-12-21
NO20072832L (no) 2007-08-01
KR101285645B1 (ko) 2013-07-12
AR053098A1 (es) 2007-04-25

Similar Documents

Publication Publication Date Title
TW200615266A (en) Organic compounds
UA84712C2 (en) N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors
TW200728307A (en) Novel spirochromanone derivatives
PH12014502721A1 (en) IMIDAZO[1,2-b] PYRIDAZINE DERIVATIVES AS KINASE INHIBITORS
MY140638A (en) New heterocyclic compounds, which are active as inhibitors of beta-lactamases
TW200740776A (en) N-phenylbenzotriazolyl c-kit inhibitors
EA200501936A1 (ru) Производные пиридо[2,1-a]изохинолина в качестве ингибиторов dpp-iv
WO2005110410A3 (en) Kinase inhibitors as therapeutic agents
WO2005075425A3 (en) Substituted bisarylurea derivatives as kinase inhibitors
IL157254A0 (en) N-substituted nonaryl-heterocyclic nmda/mr2b antagonists
TW200612958A (en) Substituted imidazole derivatives
MX2010008818A (es) Derivado de bicicloamina.
UA83875C2 (ru) Производные хинолина для применения в качестве микобактериальных ингибиторов
WO2005021544A3 (en) N3-substituted imidazopyridine-derivatives as c-kit inhibitors
MX2009008779A (es) Composicion farmacéutica que comprende derivado de pirazina y método para usar el derivado de pirazina en combinación.
MXPA06009475A (es) Derivados de quinazolina y usos terapeuticos de los mismos.
TW200736229A (en) Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors
NO20080033L (no) Kinolinderivater som NK3-antagonister
MXPA05013151A (es) 3-fluoro-piperidinas como antagonistas de n-metil-d-aspartato/nr2b.
NO20072832L (no) Smertestillende middel
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
TW200800951A (en) Substituted imidazole compounds as KSP inhibitors
EP1736157A4 (en) MEDIUM AGAINST JUCKREIZ
TW200628153A (en) Novel compounds
MXPA04009421A (es) Compuestos de tiazol-2-ilimina como inhibidores de la pde-7.

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees